CompletedNCT01514630
Creatine for Depression in Women Using Methamphetamine
About this title
Read the official source — NCT01514630Researchers studied Creatine monohydrate to find out how it affected depression symptoms in people with depression.
Medication studyAges 13–64United States
Understand this study
What did researchers investigate?
Researchers studied Creatine monohydrate to find out how it affected depression symptoms in people with depression.
Who was this study for?
Listed age limits: 13 years to 64 years.
- Listed locations
- Salt Lake CitySee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Study information
Study start dateJanuary 2013
- Recruitment status
- Completed
- Enrollment listed in the registry
- 14
- Sponsor
- Perry Renshaw
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United States
- Age range
- From 13 Years to 64 Years
- Official registry ID
- NCT01514630
- Official title
Show the full official title
Creatine as a Treatment Option for Depression in Methamphetamine Using Females
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Salt Lake City
Interested in joining this study?
Questions about this study
What did researchers investigate?
Researchers studied Creatine monohydrate to find out how it affected depression symptoms in people with depression.
Who is behind this study?
The study sponsor is Perry Renshaw.
Did this study involve medication?
Yes. The study involved medication, including Creatine monohydrate.
Who was this study for?
Listed age limits: 13 years to 64 years.
